» Articles » PMID: 17237032

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

Abstract

The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

Citing Articles

Targeted Delivery of SmacN7 Peptide Induces Immunogenic Cell Death in Cervical Cancer Treatment.

Dai Y, Lu S, Wei L, Liu L Appl Biochem Biotechnol. 2025; .

PMID: 39862369 DOI: 10.1007/s12010-024-05129-5.


The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review.

Bhalerao V, Gotarkar S, Muneshwar K J Family Med Prim Care. 2024; 13(11):4775-4782.

PMID: 39722908 PMC: 11668371. DOI: 10.4103/jfmpc.jfmpc_235_24.


Geographic variation of HPV-associated cancer incidence in Kentucky using spatial scan statistics.

Trott S, Lei F, Christian W, Mao X, Lehmkuhl B, Kejner A Cancer Causes Control. 2024; 35(5):817-824.

PMID: 38212533 PMC: 11346267. DOI: 10.1007/s10552-023-01835-3.


Mothers' intention to vaccinate their daughters against human papillomavirus in NorthWest Ethiopia, using the theory of planned behavior.

Tilahun S, Wondiye H, Yigzaw Z Hum Vaccin Immunother. 2023; 19(3):2288390.

PMID: 38111322 PMC: 10760316. DOI: 10.1080/21645515.2023.2288390.


Essential cancer medicines and cancer outcomes: Cross-sectional study of 124 countries.

Ikpeni O, Maraj D, Woods H, Workentin A, Booth C, Persaud N Cancer Med. 2023; 12(22):20745-20758.

PMID: 37902259 PMC: 10709725. DOI: 10.1002/cam4.6642.